{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:50:32Z","timestamp":1764251432256},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372180"],"award-info":[{"award-number":["81372180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.prp.2016.04.006","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T11:35:47Z","timestamp":1461929747000},"page":"636-642","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The clinical pathological significance of Thy1 and CD49f expression in chondrosarcomas"],"prefix":"10.1016","volume":"212","author":[{"given":"Lile","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhulin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2016.04.006_bib0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/1097-0142(19800101)45:1<149::AID-CNCR2820450125>3.0.CO;2-A","article-title":"Chondrosarcoma: a clinicopathologic and statistical analysis","volume":"45","author":"Pritchard","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2016.04.006_bib0010","doi-asserted-by":"crossref","first-page":"405437","DOI":"10.1155\/2011\/405437","article-title":"Chondrosarcoma: with updates on molecular genetics","volume":"2011","author":"Kim","year":"2011","journal-title":"Sarcoma"},{"key":"10.1016\/j.prp.2016.04.006_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4614-8090-7_1","article-title":"Thy-1 modulates neurological cell-cell and cell-matrix interactions through multiple molecular interactions","volume":"8","author":"Leyton","year":"2014","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.prp.2016.04.006_bib0020","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.yexcr.2010.06.013","article-title":"Thymus cell antigen 1 (Thy1, CD90) is expressed by lymphatic vessels and mediates cell adhesion to lymphatic endothelium","volume":"316","author":"Jurisic","year":"2010","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.prp.2016.04.006_bib0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbrc.2010.04.092","article-title":"Anomalous expression of Thy1 (CD90) in B-cell lymphoma cells and proliferation inhibition by anti-Thy1 antibody treatment","volume":"396","author":"Ishiura","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2016.04.006_bib0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00383-007-2033-4","article-title":"Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival","volume":"24","author":"Fiegel","year":"2008","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.prp.2016.04.006_bib0035","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ijc.25047","article-title":"Functional characterization of THY1 as a tumor suppressor gene with antiinvasive activity in nasopharyngeal carcinoma","volume":"127","author":"Lung","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.04.006_bib0040","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.acthis.2011.01.001","article-title":"Overexpression of Thy1\/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis","volume":"113","author":"Lu","year":"2011","journal-title":"Acta Histochem."},{"key":"10.1016\/j.prp.2016.04.006_bib0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-4608(02)00855-5","article-title":"THY1 expression is associated with tumor suppression of human ovarian cancer","volume":"143","author":"Abeysinghe","year":"2003","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.prp.2016.04.006_bib0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00432-004-0614-3","article-title":"Basement membrane proteins play an active role in the invasive process of human hepatocellullar carcinoma cells with high metastasis potential","volume":"131","author":"Tian","year":"2005","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.prp.2016.04.006_bib0055","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3892\/ijo.2013.2097","article-title":"Integrin alpha 6: a novel therapeutic target in esophageal squamous cell carcinoma","volume":"43","author":"Kwon","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2016.04.006_bib0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6890-13-16","article-title":"Expression of integrin genes and proteins in progression and dissemination of colorectal adenocarcinoma","volume":"13","author":"Denadai","year":"2013","journal-title":"BMC Clin. Pathol."},{"key":"10.1016\/j.prp.2016.04.006_bib0065","doi-asserted-by":"crossref","first-page":"e72438","DOI":"10.1371\/journal.pone.0072438","article-title":"CD49f(high) cells retain sphere-forming and tumor-initiating activities in human gastric tumors","volume":"8","author":"Fukamachi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2016.04.006_bib0070","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.249","article-title":"High CD49f expression is associated with osteosarcoma tumor progression: a study using patient-derived primary cell cultures","author":"Penfornis","year":"2014","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2016.04.006_bib0075","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1038\/onc.2012.438","article-title":"Human osteosarcoma CD49f(\u2212)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity","volume":"32","author":"Ying","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2016.04.006_bib0080","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/bonekey.2013.112","article-title":"Targeted therapies for bone sarcomas","volume":"2","author":"Heymann","year":"2013","journal-title":"Bonekey Rep."},{"key":"10.1016\/j.prp.2016.04.006_bib0085","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ijc.27984","article-title":"The dual role of the novel Wnt receptor tyrosine kinase ROR2, in human carcinogenesis","volume":"133","author":"Ford","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2016.04.006_bib0090","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrm3470","article-title":"The complex world of WNT receptor signaling","volume":"13","author":"Niehrs","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2016.04.006_bib0095","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1038\/sj.onc.1208559","article-title":"Interaction of human Thy-1 (CD 90) with the integrin alphavbeta3 (CD51\/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium","volume":"24","author":"Saalbach","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2016.04.006_bib0100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajpath.2012.10.003","article-title":"Melanoma cells use Thy-1 (CD90) on endothelial cells for metastasis formation","volume":"182","author":"Schubert","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2016.04.006_bib0105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cancergencyto.2005.02.014","article-title":"THY-1 induction is associated with up-regulation of fibronectin and thrombospondin-1 in human ovarian cancer","volume":"161","author":"Abeysinghe","year":"2005","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.prp.2016.04.006_bib0110","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/modpathol.2010.122","article-title":"CD90\/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker","volume":"23","author":"True","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2016.04.006_bib0115","first-page":"675","article-title":"Novel biomarker candidates for gastric cancer","volume":"19","author":"Yang","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2016.04.006_bib0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-4608(02)00855-5","article-title":"THY1 expression is associated with tumor suppression of human ovarian cancer","volume":"143","author":"Abeysinghe","year":"2003","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.prp.2016.04.006_bib0125","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004994","article-title":"Integrin structure, activation, and interactions","volume":"3","author":"Campbell","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.prp.2016.04.006_bib0130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6890-13-16","article-title":"Expression of integrin genes and proteins in progression and dissemination of colorectal adenocarcinoma","volume":"13","author":"Denadai","year":"2013","journal-title":"BMC Clin. Pathol."},{"key":"10.1016\/j.prp.2016.04.006_bib0135","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3892\/ijo.2013.1955","article-title":"CD49f-positive cell population efficiently enriches colon cancer-initiating cells","volume":"43","author":"Haraguchi","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2016.04.006_bib0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/2047-783X-18-52","article-title":"RNA interference targeting human integrin \u03b16 suppresses the metastasis potential of hepatocellular carcinoma cells","volume":"18","author":"Lv","year":"2013","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.prp.2016.04.006_bib0145","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3892\/ijo.2013.2097","article-title":"Integrin alpha 6: a novel therapeutic target in esophageal squamous cell carcinoma","volume":"43","author":"Kwon","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2016.04.006_bib0150","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/stem.1075","article-title":"P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer","volume":"30","author":"Vieira","year":"2012","journal-title":"Stem Cells"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816300735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816300735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T03:04:08Z","timestamp":1718507048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033816300735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0344033816300735"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2016.04.006","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical pathological significance of Thy1 and CD49f expression in chondrosarcomas","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2016.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}